Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature
| Autor: | Gökhan Gökçe, Erol Çakmak, Pınar Gökçen, Kaan Gökçen |
|---|---|
| Přispěvatelé: | [Gokcen, Pinar -- Cakmak, Erol] Cumhuriyet Univ, Sch Med, Dept Gastroenterol, Sivas, Turkey -- [Gokcen, Kaan -- Gokce, Gokhan] Cumhuriyet Univ, Sch Med, Dept Urol, Sivas, Turkey |
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Cholestasis business.industry Jaundice medicine.disease paraneoplastic syndrome prostate cancer Gastroenterology Primary tumor Metastasis Prostate cancer Renal cell carcinoma Internal medicine Ascites medicine peritonitis carcinomatosa Outpatient clinic medicine.symptom business Urooncology |
| Popis: | WOS: 000459394900014 PubMed ID: 30668309 Paraneoplastic syndromes are functional clinical disorders caused by the direct effect of the primary tumor or metastasis. The initial presenting symptom of the patients may be associated with paraneoplastic manifestations. Paraneoplastic cholestasis is most frequently defined in association with renal cell carcinoma (Stauffer's syndrome), but it is an extremely rare clinical entity seen in association with prostate cancer. Etiology of cholestasis was investigated in the case diagnosed as metastatic prostate cancer who applied to the gastroenterology outpatient clinic due to complaints of ascites and jaundice that established the diagnosis of paraneoplastic hyperbilirubinemia. We observed improvement of his cholestasis with hormonotherapy used for prostate cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|